nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—TUBB—Vinorelbine—ovarian cancer	0.266	0.338	CbGbCtD
Podofilox—TUBB—Paclitaxel—ovarian cancer	0.187	0.237	CbGbCtD
Podofilox—TUBB—Docetaxel—ovarian cancer	0.135	0.172	CbGbCtD
Podofilox—TOP2A—Epirubicin—ovarian cancer	0.101	0.128	CbGbCtD
Podofilox—TOP2A—Doxorubicin—ovarian cancer	0.0535	0.068	CbGbCtD
Podofilox—CYP3A4—Topotecan—ovarian cancer	0.0161	0.0204	CbGbCtD
Podofilox—CYP3A4—Vinorelbine—ovarian cancer	0.0113	0.0144	CbGbCtD
Podofilox—CYP3A4—Paclitaxel—ovarian cancer	0.00796	0.0101	CbGbCtD
Podofilox—CYP3A4—Docetaxel—ovarian cancer	0.00576	0.00731	CbGbCtD
Podofilox—CYP3A4—Doxorubicin—ovarian cancer	0.00429	0.00545	CbGbCtD
Podofilox—TUBA4A—myometrium—ovarian cancer	0.00328	0.0474	CbGeAlD
Podofilox—TUBA4A—epithelium—ovarian cancer	0.00257	0.0372	CbGeAlD
Podofilox—TUBA4A—uterine cervix—ovarian cancer	0.00255	0.0369	CbGeAlD
Podofilox—TUBA4A—decidua—ovarian cancer	0.00243	0.0351	CbGeAlD
Podofilox—TOP2A—myometrium—ovarian cancer	0.00242	0.035	CbGeAlD
Podofilox—TUBB—myometrium—ovarian cancer	0.0024	0.0347	CbGeAlD
Podofilox—TUBA4A—endometrium—ovarian cancer	0.00231	0.0333	CbGeAlD
Podofilox—TUBA4A—gonad—ovarian cancer	0.00214	0.0309	CbGeAlD
Podofilox—TUBA4A—uterus—ovarian cancer	0.00212	0.0307	CbGeAlD
Podofilox—TUBA4A—female reproductive system—ovarian cancer	0.00191	0.0276	CbGeAlD
Podofilox—TOP2A—uterine cervix—ovarian cancer	0.00189	0.0273	CbGeAlD
Podofilox—TUBB—uterine cervix—ovarian cancer	0.00187	0.027	CbGeAlD
Podofilox—TUBA4A—bone marrow—ovarian cancer	0.0018	0.0261	CbGeAlD
Podofilox—TOP2A—decidua—ovarian cancer	0.0018	0.026	CbGeAlD
Podofilox—TUBB—decidua—ovarian cancer	0.00178	0.0257	CbGeAlD
Podofilox—TUBA4A—female gonad—ovarian cancer	0.00174	0.0251	CbGeAlD
Podofilox—TUBA4A—vagina—ovarian cancer	0.00173	0.025	CbGeAlD
Podofilox—TOP2A—endometrium—ovarian cancer	0.0017	0.0247	CbGeAlD
Podofilox—TUBB—endometrium—ovarian cancer	0.00169	0.0244	CbGeAlD
Podofilox—TOP2A—uterus—ovarian cancer	0.00157	0.0227	CbGeAlD
Podofilox—TUBB—uterus—ovarian cancer	0.00156	0.0225	CbGeAlD
Podofilox—TUBA4A—testis—ovarian cancer	0.00154	0.0223	CbGeAlD
Podofilox—Skin ulcer—Melphalan—ovarian cancer	0.00144	0.027	CcSEcCtD
Podofilox—Tingling sensation—Melphalan—ovarian cancer	0.0014	0.0262	CcSEcCtD
Podofilox—Blister—Vinorelbine—ovarian cancer	0.00136	0.0255	CcSEcCtD
Podofilox—TOP2A—bone marrow—ovarian cancer	0.00133	0.0193	CbGeAlD
Podofilox—TUBB—bone marrow—ovarian cancer	0.00132	0.0191	CbGeAlD
Podofilox—TOP2A—female gonad—ovarian cancer	0.00129	0.0186	CbGeAlD
Podofilox—TOP2A—vagina—ovarian cancer	0.00128	0.0185	CbGeAlD
Podofilox—TUBB—female gonad—ovarian cancer	0.00127	0.0184	CbGeAlD
Podofilox—TUBB—vagina—ovarian cancer	0.00127	0.0183	CbGeAlD
Podofilox—Ulcer—Melphalan—ovarian cancer	0.00119	0.0222	CcSEcCtD
Podofilox—TOP2A—testis—ovarian cancer	0.00114	0.0165	CbGeAlD
Podofilox—TUBB—testis—ovarian cancer	0.00113	0.0163	CbGeAlD
Podofilox—TUBA4A—lymph node—ovarian cancer	0.00112	0.0162	CbGeAlD
Podofilox—NR3C1—myometrium—ovarian cancer	0.00111	0.0161	CbGeAlD
Podofilox—TOP2A—Docetaxel—Paclitaxel—ovarian cancer	0.0011	0.219	CbGdCrCtD
Podofilox—Skin exfoliation—Melphalan—ovarian cancer	0.00107	0.0201	CcSEcCtD
Podofilox—NR3C1—embryo—ovarian cancer	0.00107	0.0155	CbGeAlD
Podofilox—Redness—Paclitaxel—ovarian cancer	0.000977	0.0183	CcSEcCtD
Podofilox—TOP2A—Irinotecan—Topotecan—ovarian cancer	0.000944	0.187	CbGdCrCtD
Podofilox—Skin exfoliation—Vinorelbine—ovarian cancer	0.000936	0.0175	CcSEcCtD
Podofilox—NR3C1—epithelium—ovarian cancer	0.000873	0.0126	CbGeAlD
Podofilox—Dermatitis bullous—Topotecan—ovarian cancer	0.00087	0.0163	CcSEcCtD
Podofilox—NR3C1—uterine cervix—ovarian cancer	0.000866	0.0125	CbGeAlD
Podofilox—Dizziness—Altretamine—ovarian cancer	0.000855	0.016	CcSEcCtD
Podofilox—Skin ulcer—Paclitaxel—ovarian cancer	0.000847	0.0159	CcSEcCtD
Podofilox—Redness—Docetaxel—ovarian cancer	0.000828	0.0155	CcSEcCtD
Podofilox—TOP2A—lymph node—ovarian cancer	0.000826	0.012	CbGeAlD
Podofilox—NR3C1—decidua—ovarian cancer	0.000825	0.0119	CbGeAlD
Podofilox—Vomiting—Altretamine—ovarian cancer	0.000822	0.0154	CcSEcCtD
Podofilox—Tingling sensation—Paclitaxel—ovarian cancer	0.00082	0.0154	CcSEcCtD
Podofilox—TUBB—lymph node—ovarian cancer	0.000819	0.0118	CbGeAlD
Podofilox—NR3C1—endometrium—ovarian cancer	0.000783	0.0113	CbGeAlD
Podofilox—Pain—Carboplatin—ovarian cancer	0.000764	0.0143	CcSEcCtD
Podofilox—Tenderness—Paclitaxel—ovarian cancer	0.000756	0.0142	CcSEcCtD
Podofilox—CYP2C19—vagina—ovarian cancer	0.00075	0.0109	CbGeAlD
Podofilox—Dermatitis bullous—Vinorelbine—ovarian cancer	0.000745	0.014	CcSEcCtD
Podofilox—Skin discolouration—Paclitaxel—ovarian cancer	0.00073	0.0137	CcSEcCtD
Podofilox—NR3C1—gonad—ovarian cancer	0.000726	0.0105	CbGeAlD
Podofilox—NR3C1—uterus—ovarian cancer	0.000721	0.0104	CbGeAlD
Podofilox—TOP2A—Vindesine—Vinorelbine—ovarian cancer	0.000701	0.139	CbGdCrCtD
Podofilox—NR3C1—female reproductive system—ovarian cancer	0.000649	0.00938	CbGeAlD
Podofilox—Skin exfoliation—Paclitaxel—ovarian cancer	0.00063	0.0118	CcSEcCtD
Podofilox—NR3C1—bone marrow—ovarian cancer	0.000612	0.00886	CbGeAlD
Podofilox—NR3C1—female gonad—ovarian cancer	0.00059	0.00854	CbGeAlD
Podofilox—NR3C1—vagina—ovarian cancer	0.000587	0.00848	CbGeAlD
Podofilox—Haemoglobin—Topotecan—ovarian cancer	0.000578	0.0108	CcSEcCtD
Podofilox—Inflammation—Docetaxel—ovarian cancer	0.000576	0.0108	CcSEcCtD
Podofilox—Haemorrhage—Topotecan—ovarian cancer	0.000575	0.0108	CcSEcCtD
Podofilox—Haemoglobin—Melphalan—ovarian cancer	0.000566	0.0106	CcSEcCtD
Podofilox—Haemorrhage—Melphalan—ovarian cancer	0.000563	0.0106	CcSEcCtD
Podofilox—Redness—Epirubicin—ovarian cancer	0.000558	0.0105	CcSEcCtD
Podofilox—TOP2A—Paclitaxel—Docetaxel—ovarian cancer	0.00055	0.109	CbGdCrCtD
Podofilox—Swelling—Paclitaxel—ovarian cancer	0.000543	0.0102	CcSEcCtD
Podofilox—Skin exfoliation—Docetaxel—ovarian cancer	0.000534	0.01	CcSEcCtD
Podofilox—NR3C1—testis—ovarian cancer	0.000523	0.00757	CbGeAlD
Podofilox—Blister—Epirubicin—ovarian cancer	0.000523	0.00981	CcSEcCtD
Podofilox—Immune system disorder—Topotecan—ovarian cancer	0.00052	0.00975	CcSEcCtD
Podofilox—Redness—Doxorubicin—ovarian cancer	0.000517	0.00969	CcSEcCtD
Podofilox—Immune system disorder—Melphalan—ovarian cancer	0.000509	0.00954	CcSEcCtD
Podofilox—CYP3A4—female reproductive system—ovarian cancer	0.00049	0.00709	CbGeAlD
Podofilox—Skin ulcer—Epirubicin—ovarian cancer	0.000484	0.00908	CcSEcCtD
Podofilox—Blister—Doxorubicin—ovarian cancer	0.000484	0.00907	CcSEcCtD
Podofilox—Stinging—Epirubicin—ovarian cancer	0.000465	0.00872	CcSEcCtD
Podofilox—Swelling—Docetaxel—ovarian cancer	0.00046	0.00862	CcSEcCtD
Podofilox—Skin ulcer—Doxorubicin—ovarian cancer	0.000448	0.0084	CcSEcCtD
Podofilox—Immune system disorder—Vinorelbine—ovarian cancer	0.000445	0.00834	CcSEcCtD
Podofilox—Dry skin—Paclitaxel—ovarian cancer	0.000439	0.00823	CcSEcCtD
Podofilox—Stinging—Doxorubicin—ovarian cancer	0.000431	0.00807	CcSEcCtD
Podofilox—Erythema—Vinorelbine—ovarian cancer	0.000429	0.00803	CcSEcCtD
Podofilox—Dermatitis bullous—Docetaxel—ovarian cancer	0.000424	0.00796	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.000424	0.00794	CcSEcCtD
Podofilox—Skin discolouration—Epirubicin—ovarian cancer	0.000417	0.00782	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.000415	0.00778	CcSEcCtD
Podofilox—Oedema—Melphalan—ovarian cancer	0.0004	0.00751	CcSEcCtD
Podofilox—Ulcer—Epirubicin—ovarian cancer	0.000399	0.00747	CcSEcCtD
Podofilox—Skin disorder—Topotecan—ovarian cancer	0.000397	0.00745	CcSEcCtD
Podofilox—Pain—Chlorambucil—ovarian cancer	0.000393	0.00736	CcSEcCtD
Podofilox—Skin disorder—Melphalan—ovarian cancer	0.000389	0.00729	CcSEcCtD
Podofilox—Inflammation—Epirubicin—ovarian cancer	0.000389	0.00729	CcSEcCtD
Podofilox—Skin discolouration—Doxorubicin—ovarian cancer	0.000386	0.00724	CcSEcCtD
Podofilox—NR3C1—lymph node—ovarian cancer	0.000379	0.00549	CbGeAlD
Podofilox—TOP2A—Vincristine—Vinorelbine—ovarian cancer	0.000378	0.075	CbGdCrCtD
Podofilox—Dry skin—Docetaxel—ovarian cancer	0.000372	0.00697	CcSEcCtD
Podofilox—Ulcer—Doxorubicin—ovarian cancer	0.000369	0.00691	CcSEcCtD
Podofilox—Paraesthesia—Topotecan—ovarian cancer	0.000367	0.00688	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000362	0.00679	CcSEcCtD
Podofilox—Skin exfoliation—Epirubicin—ovarian cancer	0.00036	0.00675	CcSEcCtD
Podofilox—Inflammation—Doxorubicin—ovarian cancer	0.00036	0.00674	CcSEcCtD
Podofilox—Paraesthesia—Melphalan—ovarian cancer	0.000359	0.00674	CcSEcCtD
Podofilox—Haematuria—Paclitaxel—ovarian cancer	0.000352	0.00659	CcSEcCtD
Podofilox—Pain—Topotecan—ovarian cancer	0.00035	0.00655	CcSEcCtD
Podofilox—Pain—Melphalan—ovarian cancer	0.000342	0.00642	CcSEcCtD
Podofilox—Skin disorder—Vinorelbine—ovarian cancer	0.00034	0.00637	CcSEcCtD
Podofilox—Skin exfoliation—Doxorubicin—ovarian cancer	0.000333	0.00624	CcSEcCtD
Podofilox—Haemoglobin—Paclitaxel—ovarian cancer	0.000333	0.00624	CcSEcCtD
Podofilox—Haemorrhage—Paclitaxel—ovarian cancer	0.000331	0.00621	CcSEcCtD
Podofilox—Pruritus—Chlorambucil—ovarian cancer	0.000325	0.00609	CcSEcCtD
Podofilox—Paraesthesia—Vinorelbine—ovarian cancer	0.000314	0.00589	CcSEcCtD
Podofilox—TOP2A—Vinblastine—Vinorelbine—ovarian cancer	0.000304	0.0603	CbGdCrCtD
Podofilox—Pain—Vinorelbine—ovarian cancer	0.000299	0.00561	CcSEcCtD
Podofilox—Immune system disorder—Paclitaxel—ovarian cancer	0.000299	0.00561	CcSEcCtD
Podofilox—Vomiting—Chlorambucil—ovarian cancer	0.000292	0.00547	CcSEcCtD
Podofilox—Pruritus—Topotecan—ovarian cancer	0.000289	0.00542	CcSEcCtD
Podofilox—Erythema—Paclitaxel—ovarian cancer	0.000288	0.0054	CcSEcCtD
Podofilox—Dermatitis bullous—Epirubicin—ovarian cancer	0.000286	0.00537	CcSEcCtD
Podofilox—Pruritus—Melphalan—ovarian cancer	0.000283	0.00531	CcSEcCtD
Podofilox—Haemoglobin—Docetaxel—ovarian cancer	0.000282	0.00529	CcSEcCtD
Podofilox—Haemorrhage—Docetaxel—ovarian cancer	0.000281	0.00526	CcSEcCtD
Podofilox—Dizziness—Topotecan—ovarian cancer	0.00027	0.00507	CcSEcCtD
Podofilox—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000265	0.00497	CcSEcCtD
Podofilox—Vomiting—Topotecan—ovarian cancer	0.00026	0.00487	CcSEcCtD
Podofilox—Rash—Topotecan—ovarian cancer	0.000258	0.00483	CcSEcCtD
Podofilox—Dermatitis—Topotecan—ovarian cancer	0.000258	0.00483	CcSEcCtD
Podofilox—Headache—Topotecan—ovarian cancer	0.000256	0.0048	CcSEcCtD
Podofilox—Vomiting—Melphalan—ovarian cancer	0.000255	0.00477	CcSEcCtD
Podofilox—Immune system disorder—Docetaxel—ovarian cancer	0.000254	0.00475	CcSEcCtD
Podofilox—Rash—Melphalan—ovarian cancer	0.000252	0.00473	CcSEcCtD
Podofilox—Dermatitis—Melphalan—ovarian cancer	0.000252	0.00473	CcSEcCtD
Podofilox—Dry skin—Epirubicin—ovarian cancer	0.000251	0.0047	CcSEcCtD
Podofilox—Pruritus—Vinorelbine—ovarian cancer	0.000247	0.00464	CcSEcCtD
Podofilox—Erythema—Docetaxel—ovarian cancer	0.000244	0.00458	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000244	0.00457	CcSEcCtD
Podofilox—Oedema—Paclitaxel—ovarian cancer	0.000235	0.00441	CcSEcCtD
Podofilox—Dry skin—Doxorubicin—ovarian cancer	0.000232	0.00435	CcSEcCtD
Podofilox—Dizziness—Vinorelbine—ovarian cancer	0.000231	0.00434	CcSEcCtD
Podofilox—Skin disorder—Paclitaxel—ovarian cancer	0.000229	0.00428	CcSEcCtD
Podofilox—Vomiting—Vinorelbine—ovarian cancer	0.000222	0.00417	CcSEcCtD
Podofilox—Rash—Vinorelbine—ovarian cancer	0.000221	0.00413	CcSEcCtD
Podofilox—Dermatitis—Vinorelbine—ovarian cancer	0.00022	0.00413	CcSEcCtD
Podofilox—Headache—Vinorelbine—ovarian cancer	0.000219	0.00411	CcSEcCtD
Podofilox—Insomnia—Paclitaxel—ovarian cancer	0.000213	0.00399	CcSEcCtD
Podofilox—Paraesthesia—Paclitaxel—ovarian cancer	0.000211	0.00396	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000207	0.00387	CcSEcCtD
Podofilox—Pain—Paclitaxel—ovarian cancer	0.000201	0.00377	CcSEcCtD
Podofilox—Haematuria—Epirubicin—ovarian cancer	0.000201	0.00377	CcSEcCtD
Podofilox—Oedema—Docetaxel—ovarian cancer	0.000199	0.00374	CcSEcCtD
Podofilox—Skin disorder—Docetaxel—ovarian cancer	0.000194	0.00363	CcSEcCtD
Podofilox—Haemoglobin—Epirubicin—ovarian cancer	0.00019	0.00357	CcSEcCtD
Podofilox—Haemorrhage—Epirubicin—ovarian cancer	0.000189	0.00355	CcSEcCtD
Podofilox—Haematuria—Doxorubicin—ovarian cancer	0.000186	0.00349	CcSEcCtD
Podofilox—TOP2A—Idarubicin—Epirubicin—ovarian cancer	0.000184	0.0365	CbGdCrCtD
Podofilox—TOP2A—Doxorubicin—Epirubicin—ovarian cancer	0.000184	0.0365	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Epirubicin—ovarian cancer	0.000184	0.0365	CbGdCrCtD
Podofilox—Insomnia—Docetaxel—ovarian cancer	0.00018	0.00338	CcSEcCtD
Podofilox—Paraesthesia—Docetaxel—ovarian cancer	0.000179	0.00336	CcSEcCtD
Podofilox—Haemoglobin—Doxorubicin—ovarian cancer	0.000176	0.0033	CcSEcCtD
Podofilox—Haemorrhage—Doxorubicin—ovarian cancer	0.000175	0.00328	CcSEcCtD
Podofilox—Immune system disorder—Epirubicin—ovarian cancer	0.000171	0.00321	CcSEcCtD
Podofilox—TOP2A—Idarubicin—Doxorubicin—ovarian cancer	0.000171	0.0338	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Doxorubicin—ovarian cancer	0.000171	0.0338	CbGdCrCtD
Podofilox—TOP2A—Epirubicin—Doxorubicin—ovarian cancer	0.000171	0.0338	CbGdCrCtD
Podofilox—Pain—Docetaxel—ovarian cancer	0.000171	0.0032	CcSEcCtD
Podofilox—Pruritus—Paclitaxel—ovarian cancer	0.000166	0.00312	CcSEcCtD
Podofilox—Erythema—Epirubicin—ovarian cancer	0.000165	0.00309	CcSEcCtD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—IL6—ovarian cancer	0.000165	0.00193	CbGpPWpGaD
Podofilox—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000163	0.00191	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—APC—ovarian cancer	0.000162	0.00189	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—ATF3—ovarian cancer	0.000161	0.00188	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.00016	0.00187	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.00016	0.00187	CbGpPWpGaD
Podofilox—Immune system disorder—Doxorubicin—ovarian cancer	0.000158	0.00297	CcSEcCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000157	0.00184	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	0.000156	0.00182	CbGpPWpGaD
Podofilox—Dizziness—Paclitaxel—ovarian cancer	0.000156	0.00292	CcSEcCtD
Podofilox—TOP2A—Cell Cycle—RBL2—ovarian cancer	0.000155	0.00181	CbGpPWpGaD
Podofilox—Erythema—Doxorubicin—ovarian cancer	0.000152	0.00286	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	0.000152	0.00177	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TYMS—ovarian cancer	0.000151	0.00176	CbGpPWpGaD
Podofilox—Vomiting—Paclitaxel—ovarian cancer	0.00015	0.0028	CcSEcCtD
Podofilox—TUBB—Cell Cycle—MLH1—ovarian cancer	0.000149	0.00174	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CCND2—ovarian cancer	0.000149	0.00174	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—ovarian cancer	0.000149	0.00174	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	0.000148	0.00174	CbGpPWpGaD
Podofilox—Rash—Paclitaxel—ovarian cancer	0.000148	0.00278	CcSEcCtD
Podofilox—Dermatitis—Paclitaxel—ovarian cancer	0.000148	0.00278	CcSEcCtD
Podofilox—TUBB—Cell Cycle—SKP2—ovarian cancer	0.000148	0.00173	CbGpPWpGaD
Podofilox—Headache—Paclitaxel—ovarian cancer	0.000147	0.00276	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle—CHEK2—ovarian cancer	0.000142	0.00166	CbGpPWpGaD
Podofilox—Pruritus—Docetaxel—ovarian cancer	0.000141	0.00264	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	0.00014	0.00164	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—NR5A1—ovarian cancer	0.00014	0.00163	CbGpPWpGaD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000139	0.00261	CcSEcCtD
Podofilox—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000136	0.00159	CbGpPWpGaD
Podofilox—Oedema—Epirubicin—ovarian cancer	0.000134	0.00252	CcSEcCtD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000134	0.00157	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—SOD1—ovarian cancer	0.000134	0.00156	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CCND2—ovarian cancer	0.000133	0.00156	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—BRCA1—ovarian cancer	0.000133	0.00156	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PPP2R1A—ovarian cancer	0.000133	0.00155	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	0.000132	0.00155	CbGpPWpGaD
Podofilox—Dizziness—Docetaxel—ovarian cancer	0.000132	0.00247	CcSEcCtD
Podofilox—Skin disorder—Epirubicin—ovarian cancer	0.000131	0.00245	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CCNE1—ovarian cancer	0.00013	0.00152	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000129	0.00151	CbGpPWpGaD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000129	0.00242	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle, Mitotic—TYMS—ovarian cancer	0.000128	0.0015	CbGpPWpGaD
Podofilox—Vomiting—Docetaxel—ovarian cancer	0.000127	0.00238	CcSEcCtD
Podofilox—TUBB—Cell Cycle, Mitotic—CCND2—ovarian cancer	0.000126	0.00148	CbGpPWpGaD
Podofilox—Rash—Docetaxel—ovarian cancer	0.000126	0.00236	CcSEcCtD
Podofilox—Dermatitis—Docetaxel—ovarian cancer	0.000126	0.00235	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle—PPP2R1A—ovarian cancer	0.000125	0.00147	CbGpPWpGaD
Podofilox—Headache—Docetaxel—ovarian cancer	0.000125	0.00234	CcSEcCtD
Podofilox—Oedema—Doxorubicin—ovarian cancer	0.000124	0.00233	CcSEcCtD
Podofilox—Etoposide—ABCB1—ovarian cancer	0.000124	1	CrCbGaD
Podofilox—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000123	0.00144	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000122	0.00143	CbGpPWpGaD
Podofilox—Insomnia—Epirubicin—ovarian cancer	0.000122	0.00228	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—IL2—ovarian cancer	0.000121	0.00142	CbGpPWpGaD
Podofilox—Skin disorder—Doxorubicin—ovarian cancer	0.000121	0.00227	CcSEcCtD
Podofilox—Paraesthesia—Epirubicin—ovarian cancer	0.000121	0.00226	CcSEcCtD
Podofilox—TUBB—Cell Cycle—CHEK2—ovarian cancer	0.000121	0.00141	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—BRCA2—ovarian cancer	0.00012	0.00141	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	0.000119	0.00139	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	0.000119	0.00139	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CCNE1—ovarian cancer	0.000116	0.00136	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CXCL8—ovarian cancer	0.000116	0.00136	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—SKP2—ovarian cancer	0.000115	0.00135	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000115	0.00135	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—BIRC5—ovarian cancer	0.000115	0.00135	CbGpPWpGaD
Podofilox—Pain—Epirubicin—ovarian cancer	0.000115	0.00216	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle—TYMS—ovarian cancer	0.000114	0.00134	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CDKN1B—ovarian cancer	0.000113	0.00133	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CCND2—ovarian cancer	0.000113	0.00132	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—BRCA1—ovarian cancer	0.000113	0.00132	CbGpPWpGaD
Podofilox—Insomnia—Doxorubicin—ovarian cancer	0.000113	0.00211	CcSEcCtD
Podofilox—Paraesthesia—Doxorubicin—ovarian cancer	0.000112	0.00209	CcSEcCtD
Podofilox—NR3C1—AP-1 transcription factor network—IL2—ovarian cancer	0.000111	0.0013	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CCNE1—ovarian cancer	0.000111	0.0013	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—CTNNB1—ovarian cancer	0.00011	0.00128	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ovarian cancer	0.000109	0.00128	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—TYMS—ovarian cancer	0.000109	0.00127	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CCND1—ovarian cancer	0.000108	0.00127	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CTNNB1—ovarian cancer	0.000107	0.00125	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—PPP2R1A—ovarian cancer	0.000107	0.00125	CbGpPWpGaD
Podofilox—Pain—Doxorubicin—ovarian cancer	0.000106	0.002	CcSEcCtD
Podofilox—NR3C1—AP-1 transcription factor network—MMP9—ovarian cancer	0.000105	0.00123	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—PTEN—ovarian cancer	0.000104	0.00122	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CCND1—ovarian cancer	0.000104	0.00122	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MLH1—ovarian cancer	0.000104	0.00122	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	0.000103	0.00121	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—SKP2—ovarian cancer	0.000103	0.00121	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—BIRC5—ovarian cancer	0.000103	0.0012	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—ovarian cancer	0.000102	0.0012	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—BRCA2—ovarian cancer	0.000102	0.0012	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—IL6ST—ovarian cancer	0.0001	0.00117	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TERT—ovarian cancer	9.96e-05	0.00117	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	9.95e-05	0.00116	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CCNE1—ovarian cancer	9.9e-05	0.00116	CbGpPWpGaD
Podofilox—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	9.82e-05	0.00115	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL2—ovarian cancer	9.79e-05	0.00114	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—BIRC5—ovarian cancer	9.78e-05	0.00114	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	9.78e-05	0.00114	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—CAV1—ovarian cancer	9.77e-05	0.00114	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	9.76e-05	0.00114	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TYMS—ovarian cancer	9.73e-05	0.00114	CbGpPWpGaD
Podofilox—Pruritus—Epirubicin—ovarian cancer	9.52e-05	0.00178	CcSEcCtD
Podofilox—NR3C1—Gene Expression—WDR77—ovarian cancer	9.44e-05	0.0011	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	9.29e-05	0.00109	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	8.96e-05	0.00105	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CG—ovarian cancer	8.9e-05	0.00104	CbGpPWpGaD
Podofilox—Dizziness—Epirubicin—ovarian cancer	8.89e-05	0.00167	CcSEcCtD
Podofilox—TOP2A—Cell Cycle, Mitotic—CCND2—ovarian cancer	8.84e-05	0.00103	CbGpPWpGaD
Podofilox—Pruritus—Doxorubicin—ovarian cancer	8.8e-05	0.00165	CcSEcCtD
Podofilox—TUBB—Cell Cycle—BIRC5—ovarian cancer	8.75e-05	0.00102	CbGpPWpGaD
Podofilox—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	8.73e-05	0.00102	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—MYC—ovarian cancer	8.68e-05	0.00102	CbGpPWpGaD
Podofilox—Vomiting—Epirubicin—ovarian cancer	8.55e-05	0.0016	CcSEcCtD
Podofilox—Rash—Epirubicin—ovarian cancer	8.48e-05	0.00159	CcSEcCtD
Podofilox—TUBB—Cell Cycle—TERT—ovarian cancer	8.47e-05	0.000991	CbGpPWpGaD
Podofilox—Dermatitis—Epirubicin—ovarian cancer	8.47e-05	0.00159	CcSEcCtD
Podofilox—TOP2A—Cell Cycle—CHEK2—ovarian cancer	8.44e-05	0.000987	CbGpPWpGaD
Podofilox—Headache—Epirubicin—ovarian cancer	8.43e-05	0.00158	CcSEcCtD
Podofilox—TOP2A—Mitotic G1-G1/S phases—MYC—ovarian cancer	8.38e-05	0.00098	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	8.34e-05	0.000976	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	8.29e-05	0.00097	CbGpPWpGaD
Podofilox—Dizziness—Doxorubicin—ovarian cancer	8.23e-05	0.00154	CcSEcCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	8.13e-05	0.000951	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	8.07e-05	0.000944	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	8.06e-05	0.000943	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—YAP1—ovarian cancer	7.97e-05	0.000932	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	7.91e-05	0.000925	CbGpPWpGaD
Podofilox—Vomiting—Doxorubicin—ovarian cancer	7.91e-05	0.00148	CcSEcCtD
Podofilox—TOP2A—Cell Cycle—CCND2—ovarian cancer	7.91e-05	0.000925	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—BRCA1—ovarian cancer	7.91e-05	0.000925	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—ovarian cancer	7.87e-05	0.00092	CbGpPWpGaD
Podofilox—Rash—Doxorubicin—ovarian cancer	7.85e-05	0.00147	CcSEcCtD
Podofilox—Dermatitis—Doxorubicin—ovarian cancer	7.84e-05	0.00147	CcSEcCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	7.84e-05	0.000916	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CD—ovarian cancer	7.82e-05	0.000915	CbGpPWpGaD
Podofilox—Headache—Doxorubicin—ovarian cancer	7.8e-05	0.00146	CcSEcCtD
Podofilox—TOP2A—Cell Cycle, Mitotic—CCNE1—ovarian cancer	7.75e-05	0.000906	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	7.73e-05	0.000904	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	7.64e-05	0.000893	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—TYMS—ovarian cancer	7.61e-05	0.00089	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—ovarian cancer	7.49e-05	0.000875	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—PPP2R1A—ovarian cancer	7.46e-05	0.000872	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—TTF1—ovarian cancer	7.41e-05	0.000866	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—PTEN—ovarian cancer	7.33e-05	0.000857	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—BRCA2—ovarian cancer	7.15e-05	0.000836	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TP53—ovarian cancer	7.13e-05	0.000834	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	7.13e-05	0.000834	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	7.03e-05	0.000822	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—PGR—ovarian cancer	6.96e-05	0.000814	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CCNE1—ovarian cancer	6.93e-05	0.00081	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	6.9e-05	0.000807	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—BIRC5—ovarian cancer	6.84e-05	0.0008	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CB—ovarian cancer	6.82e-05	0.000797	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TYMS—ovarian cancer	6.8e-05	0.000795	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	6.75e-05	0.00079	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NR5A1—ovarian cancer	6.73e-05	0.000787	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	6.59e-05	0.00077	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—CTNNB1—ovarian cancer	6.53e-05	0.000764	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—IL6—ovarian cancer	6.53e-05	0.000763	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	6.53e-05	0.000763	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—PARP1—ovarian cancer	6.47e-05	0.000756	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CCND1—ovarian cancer	6.44e-05	0.000753	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	6.35e-05	0.000742	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—TP53—ovarian cancer	6.28e-05	0.000735	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IL2—ovarian cancer	6.26e-05	0.000732	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	6.21e-05	0.000726	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	6.21e-05	0.000726	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—MMP2—ovarian cancer	6.2e-05	0.000725	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	6.12e-05	0.000716	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—BIRC5—ovarian cancer	6.12e-05	0.000715	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN1B—ovarian cancer	6.04e-05	0.000706	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TERT—ovarian cancer	5.93e-05	0.000693	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	5.86e-05	0.000686	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	5.86e-05	0.000685	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CCND1—ovarian cancer	5.76e-05	0.000674	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL6—ovarian cancer	5.75e-05	0.000673	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	5.74e-05	0.000671	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—STAT3—ovarian cancer	5.7e-05	0.000666	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	5.65e-05	0.00066	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	5.5e-05	0.000643	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CCND1—ovarian cancer	5.48e-05	0.00064	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	5.39e-05	0.00063	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	5.36e-05	0.000627	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—VEGFA—ovarian cancer	5.32e-05	0.000622	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MAPK3—ovarian cancer	5.31e-05	0.000621	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—AKT1—ovarian cancer	5.31e-05	0.000621	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—NRAS—ovarian cancer	5.26e-05	0.000615	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	5.21e-05	0.00061	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MYC—ovarian cancer	5.17e-05	0.000604	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CXCL8—ovarian cancer	5.15e-05	0.000603	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN1B—ovarian cancer	5.13e-05	0.0006	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	5.05e-05	0.000591	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—MAPK3—ovarian cancer	5.03e-05	0.000589	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TP53—ovarian cancer	5e-05	0.000585	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	4.97e-05	0.000581	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CCND1—ovarian cancer	4.9e-05	0.000573	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—MAPK1—ovarian cancer	4.79e-05	0.00056	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CTNNB1—ovarian cancer	4.75e-05	0.000556	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MAPK3—ovarian cancer	4.75e-05	0.000555	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MYC—ovarian cancer	4.62e-05	0.00054	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—IL6—ovarian cancer	4.58e-05	0.000536	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—KRAS—ovarian cancer	4.52e-05	0.000529	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MAPK1—ovarian cancer	4.52e-05	0.000529	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MAPK3—ovarian cancer	4.52e-05	0.000528	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	4.4e-05	0.000515	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MYC—ovarian cancer	4.39e-05	0.000514	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NME2—ovarian cancer	4.35e-05	0.000508	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MAPK1—ovarian cancer	4.3e-05	0.000503	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	4.29e-05	0.000501	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	4.23e-05	0.000494	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CA—ovarian cancer	4.16e-05	0.000486	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MAPK3—ovarian cancer	4.04e-05	0.000472	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TP53—ovarian cancer	4.02e-05	0.00047	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	4.02e-05	0.00047	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—IL6—ovarian cancer	3.98e-05	0.000465	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MYC—ovarian cancer	3.93e-05	0.000459	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—HRAS—ovarian cancer	3.84e-05	0.00045	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MAPK1—ovarian cancer	3.84e-05	0.000449	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—YAP1—ovarian cancer	3.84e-05	0.000449	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CCND1—ovarian cancer	3.83e-05	0.000448	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TP53—ovarian cancer	3.79e-05	0.000444	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—ESR1—ovarian cancer	3.72e-05	0.000434	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.69e-05	0.000431	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN1B—ovarian cancer	3.59e-05	0.00042	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL6—ovarian cancer	3.44e-05	0.000402	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CCND1—ovarian cancer	3.43e-05	0.000401	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—AKT1—ovarian cancer	3.39e-05	0.000397	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PGR—ovarian cancer	3.35e-05	0.000392	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—ovarian cancer	3.23e-05	0.000377	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MAPK3—ovarian cancer	3.16e-05	0.000369	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PARP1—ovarian cancer	3.11e-05	0.000364	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MYC—ovarian cancer	3.07e-05	0.000359	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	3.01e-05	0.000352	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.01e-05	0.000351	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MAPK3—ovarian cancer	2.82e-05	0.00033	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYTB—ovarian cancer	2.8e-05	0.000328	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MYC—ovarian cancer	2.75e-05	0.000321	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.74e-05	0.00032	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MAPK1—ovarian cancer	2.69e-05	0.000314	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NME2—ovarian cancer	2.61e-05	0.000306	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PPP2R1A—ovarian cancer	2.53e-05	0.000295	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPP1CC—ovarian cancer	2.45e-05	0.000286	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—BRIP1—ovarian cancer	2.45e-05	0.000286	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—ovarian cancer	2.26e-05	0.000264	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—MYC—ovarian cancer	1.93e-05	0.000226	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ESR1—ovarian cancer	1.79e-05	0.000209	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.78e-05	0.000209	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYTB—ovarian cancer	1.68e-05	0.000197	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—YAP1—ovarian cancer	1.64e-05	0.000192	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.62e-05	0.00019	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.47e-05	0.000172	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.47e-05	0.000172	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.43e-05	0.000167	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—FASN—ovarian cancer	1.34e-05	0.000157	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC5A5—ovarian cancer	1.32e-05	0.000154	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC2A1—ovarian cancer	1.27e-05	0.000149	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.25e-05	0.000146	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP1B1—ovarian cancer	1.22e-05	0.000143	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	1.08e-05	0.000126	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.08e-05	0.000126	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCB1—ovarian cancer	1e-05	0.000117	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—YAP1—ovarian cancer	9.87e-06	0.000115	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TYMS—ovarian cancer	9.86e-06	0.000115	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MAPK3—ovarian cancer	9.57e-06	0.000112	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MYC—ovarian cancer	9.3e-06	0.000109	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—FASN—ovarian cancer	8.05e-06	9.41e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CAV1—ovarian cancer	7.94e-06	9.29e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC5A5—ovarian cancer	7.92e-06	9.26e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC2A1—ovarian cancer	7.65e-06	8.94e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.59e-06	8.88e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP1B1—ovarian cancer	7.33e-06	8.57e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CG—ovarian cancer	7.24e-06	8.46e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	6.5e-06	7.6e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—AKT1—ovarian cancer	6.45e-06	7.55e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CD—ovarian cancer	6.36e-06	7.44e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCB1—ovarian cancer	6.04e-06	7.06e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TYMS—ovarian cancer	5.93e-06	6.93e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CB—ovarian cancer	5.54e-06	6.48e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTEN—ovarian cancer	4.79e-06	5.6e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CAV1—ovarian cancer	4.78e-06	5.59e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CG—ovarian cancer	4.35e-06	5.09e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.83e-06	4.47e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CA—ovarian cancer	3.38e-06	3.95e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CB—ovarian cancer	3.33e-06	3.9e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTEN—ovarian cancer	2.88e-06	3.37e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AKT1—ovarian cancer	2.76e-06	3.23e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.03e-06	2.38e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AKT1—ovarian cancer	1.66e-06	1.94e-05	CbGpPWpGaD
